LMCG Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-3,507
Closed -$442K – 274
2024
Q2
$442K Sell
3,507
-31
-0.9% -$4.86K 0.03% 254
2024
Q1
$651K Sell
3,538
-1,516
-30% -$289K 0.04% 242
2023
Q4
$909K Hold
5,054
– – 0.06% 230
2023
Q3
$804K Buy
5,054
+2,153
+74% +$352K 0.05% 231
2023
Q2
$410K Hold
2,901
– – 0.03% 264
2023
Q1
$488K Buy
2,901
+67
+2% +$12K 0.03% 255
2022
Q4
$480K Buy
2,834
+6
+0.2% +$1.09K 0.03% 259
2022
Q3
$529K Buy
2,828
+39
+1% +$8.22K 0.04% 264
2022
Q2
$453K Hold
2,789
– – 0.03% 275
2022
Q1
$525K Buy
+2,789
New +$530K 0.03% 279

Other funds holding RGEN

LMCG Investments's RGEN Position: Q3 2024 in Review

LMCG Investments sold out of Repligen (RGEN) in Q3 2024, closing a stake of 3,507 shares — an estimated $442K sold.

LMCG Investments first reported a position in RGEN in Q1 2022 and held it in 10 quarters. The position peaked at $909K in Q4 2023. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • LMCG Investments reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • LMCG Investments sold 3,507 Repligen shares in Q3 2024, an estimated $442K.
  • LMCG Investments first reported a position in Repligen in Q1 2022 and held it in 10 quarters.
  • LMCG Investments's Repligen position peaked at $909K in Q4 2023.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on LMCG Investments's 13F filing for Q3 2024, filed 29 Oct 2024.